ZNF667
Zinc finger protein 667
Also known as: FLJ14011, ZN667_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5HYK9
- Gene
- ZNF667
- Ensembl
- ENSG00000198046
- Chromosome
- 19
- Canonical length
- 610 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
610 residues, UniProt reviewed canonical sequence.
>Q5HYK9|ZNF667
1 MPSARGKSKS KAPITFGDLA IYFSQEEWEW LSPIQKDLYE DVMLENYRNL VSLGLSFRRP
61 NVITLLEKGK APWMVEPVRR RRAPDSGSKC ETKKLPPNQC NKSGQSICQK LVSAQQKAPT
121 RKSGCNKNSV LVKPKKGHSG KKPLKCNDCG KTFSRSFSLK LHQNIHTGEK PFECSNCRKA
181 FRQISSILLH QRIHSGKKSH ECNKCGESFN QRTTLILHMR IHDGKEILDC GKALSQCQSF
241 NIHQKIHVVG NVCQCRKCGK AFNQMSSLLL HKKIHNGKKT HKYNKCGRGF KKKSVFVVHK
301 RIHAGEKIPE NAKALSQSLQ QRSHHLENPF KCRKCGKLFN RISPLMLHQR IHTSEKPYKC
361 DKCDKFFRRL STLILHLRIH NGEKLYRCNK CEKVCNRHSS LIQHQKVHTK KKKLFECKEC
421 GKMFSGTANL KIHQNIHSEE KPFKCNKCSK VFGRQSFLIE HQRIHTGEKP YQCEECGKAF
481 SHRISLTRHK RIHTEDRPYE CDQCGKAFSQ SAHLAQHERI HTGEKPYTCK TCGKAFSQRT
541 SLILHERSHT GEKPYECNEC GKAFSSGSDL IRHQRSHSSE KPYECSKCGK AYSRSSSLIR
601 HQNTHSEEKALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF667 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 22 nTPM
- basal ganglia: 15 nTPM
- cerebral cortex: 11 nTPM
- hippocampal formation: 10 nTPM
- hypothalamus: 9.9 nTPM
- cerebellum: 9.4 nTPM
Single-cell type
- lactotrophs: 113 nCPM
- somatotrophs: 111 nCPM
- other brain neurons: 48 nCPM
- brain inhibitory neurons: 47 nCPM
- thyrotrophs: 46 nCPM
- brain excitatory neurons: 45 nCPM
Immune cell
- naive B-cell: 3 nTPM
- NK-cell: 2.7 nTPM
- naive CD8 T-cell: 1.9 nTPM
- plasmacytoid DC: 1.1 nTPM
- naive CD4 T-cell: 0.8 nTPM
- memory B-cell: 0.6 nTPM
Brain region
- hippocampal formation: 34 nTPM
- basal ganglia: 31 nTPM
- cerebral cortex: 30 nTPM
- hypothalamus: 29 nTPM
- amygdala: 28 nTPM
- white matter: 25 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.85
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.57
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of transcription by RNA polymerase II
- positive regulation of biosynthetic process
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription factor activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF667 as an antibody target. Whether an autoantibody or antibody against ZNF667 could matter depends on whether native ZNF667 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF667 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF667 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...